Bio-Techne (TECH) Current Assets (2009 - 2026)
Bio-Techne (TECH) recorded quarterly Current Assets of $688.0 million in Q1 2026, up 7.94% quarter-over-quarter from $637.4 million in Q4 2025, and up 9.69% on a YoY basis from $627.2 million in Q1 2025.
Bio-Techne (TECH) Current Assets (2009 - 2026) Analysis & Trends
Bio-Techne's Current Assets history runs 18 years deep, the most recent figure standing at $688.0 million for Q1 2026.
- In Q1 2026, Current Assets rose 9.69% year-over-year to $688.0 million; the TTM figure through Mar 2026 stood at $688.0 million (up 9.69% YoY), while the FY2025 annual figure was $608.3 million, down 1.48% from the prior year.
- Current Assets was $688.0 million for Q1 2026 at Bio-Techne, up from $637.4 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $688.0 million in Q1 2026 to a low of $552.0 million in Q3 2022.
- Historically, Current Assets has averaged $610.1 million across 5 years, with a median of $609.5 million in 2025.
- The sharpest annual moves came in 2022 and 2025: Current Assets grew 18.6% in 2022, then decreased 6.02% in 2025.
- A 5-year view of Current Assets shows it stood at $565.2 million in 2022, then grew by 4.5% to $590.6 million in 2023, then increased by 7.45% to $634.6 million in 2024, then advanced by 0.44% to $637.4 million in 2025, then gained by 7.94% to $688.0 million in 2026.
- The last three Current Assets figures came in at $688.0 million (Q1 2026), $637.4 million (Q4 2025), and $609.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 37.31 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 521.86 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 10.37 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.25 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 3.59 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 7.63 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 11.73 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 600.85 Mn |
| 10 | Bio-Techne | 9.04 Bn | 8.83 Bn | 208.29 Mn | 688.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 688.05 Mn |
| Dec 31, 2025 | 637.43 Mn |
| Sep 30, 2025 | 609.51 Mn |
| Jun 30, 2025 | 608.30 Mn |
| Mar 31, 2025 | 627.24 Mn |
| Dec 31, 2024 | 634.64 Mn |
| Sep 30, 2024 | 648.57 Mn |
| Jun 30, 2024 | 617.42 Mn |
| Mar 31, 2024 | 610.65 Mn |
| Dec 31, 2023 | 590.64 Mn |
| Sep 30, 2023 | 591.48 Mn |
| Jun 30, 2023 | 621.48 Mn |
| Mar 31, 2023 | 571.00 Mn |
| Dec 31, 2022 | 565.18 Mn |
| Sep 30, 2022 | 552.03 Mn |
| Jun 30, 2022 | 605.56 Mn |
| Mar 31, 2022 | 593.11 Mn |
| Dec 31, 2021 | 590.23 Mn |
| Sep 30, 2021 | 543.75 Mn |
| Jun 30, 2021 | 510.61 Mn |